Shares of Evoke plc (LON:EVOK – Get Free Report) were up 17.2% during mid-day trading on Tuesday . The stock traded as high as GBX 45.90 ($0.59) and last traded at GBX 44.30 ($0.57). Approximately 3,500,189 shares changed hands during trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.48).
Analysts Set New Price Targets
Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.79) price target on shares of Evoke in a research note on Monday, December 16th.
View Our Latest Stock Report on EVOK
Evoke Stock Up 17.2 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, analysts anticipate that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling at Evoke
In other news, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the company’s stock in a transaction dated Monday, March 31st. The shares were bought at an average price of GBX 48 ($0.61) per share, with a total value of £96,000 ($122,668.03). Also, insider Andrea Gisle Joosen bought 14,572 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 70 ($0.89) per share, with a total value of £10,200.40 ($13,033.99). 27.00% of the stock is owned by company insiders.
About Evoke
Read More
- Five stocks we like better than Evoke
- Are Penny Stocks a Good Fit for Your Portfolio?
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- How to Invest in Biotech Stocks
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.